Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Unc-51 like kinase 4 (ULK4) is a human protein encoded by the ULK4 gene and belongs to the ULK family of serine/threonine kinases. While ULK1 and ULK2 are well characterized for their roles in autophagy, ULK4's biological function is less understood but may include involvement in neuronal development and regulation of neural signaling pathways. ULK4 is not currently known to be pharmacologically targeted by any approved or investigational drugs, and its mechanism of action in disease is not well delineated from current literature. Emerging genetic evidence suggests a potential role in neurologic and psychiatric conditions, though more research is required for definitive clinical associations.
Not established for ULK4; other ULK kinases participate in autophagy regulation, but comparable pharmaceutical mechanisms for ULK4 are not described in the current literature. General mechanism for inhibitors of kinases would be inhibition of phosphorylation activity, but no ULK4-specific inhibitors are cited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unc-51 like kinase 4 (ULK4).